Trazodone on OSA Endotypes

Recruiting now · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Obstructive Sleep Apnea

In brief

Obstructive sleep apnea (OSA) is common and has major health implications but treatment options are limited. Some OSA patients with low arousal threshold wake up prematurely during an obstructive event and do not have time for spontaneous upper airway (UA) dilator muscle recruitment. As a consequence they are exposed to apnea and hypopnea cycling. In this protocol the investigators will test the effect of trazodone administered before sleep on OSA traits and OSA severity during sleep.

Key facts

Study ID
NCT06286189
Run by
Brigham and Women's Hospital
People needed
18
Starts
2024-01-01
Expected to finish
2026-06-01
Last updated by the study team
2025-02-06

Who can join

Age: 21 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.